Leap Health

We introduce employer healthcare innovations to the world

What’s the issue?

• Over 50% of self-funded employer pharmacy spend is driven by specialty drugs, a growing number of which are delivered via infusion

• Most infusions are delivered in provider settings where infusions are much more expensive and inconvenient relative to the home

• Non-adherence driven by the inconvenience of provider delivered infusions causes up to 25% of hospitalizations each year

Introducing

What they do

Leap Health provides convenient home and alternate sites of care infusions at significantly lower costs for employers and payers.

• Care navigation support to streamline and coordinate access to care

• Elimination of specialty medication markups and fee transparency

Leap Health estimates $4.5M in potential savings among the top 25 contributors to specialty medication spend per 10K covered lives.

How they do it

Leap Health coordinates care on behalf of patients through its care guide team and enables employers and payers to pay the true price of drugs by eliminating provider margin through their contracted specialty pharmacies.

• Care guides (nurses) that coordinate directly with home infusion nurses and patients to deliver care and provide 24/7 clinical support

• Integration with TPAs and carriers to identify members in need of services through claims data and prior authorizations

• Network of specialty pharmacies from which drugs are procured 30% - 60% lower cost, with no markups and transparent billing

Who they are

• Founders:

  • Rob Lahayne: Previous CEO of Touchcare

  • Hani Elias: Previous Lumere and McKinsey

  • Amir Sharif: Previous BCG and Juxtapose

• Headquarters: New York, New York

• Employee Count: 7

• Investors: Anchor Ventures

Who else is out there?

• Quantify Health

Our thoughts

SUCCESS DRIVERS

• Big, growing issue: With 50% of pharmacy spend driven by specialty medications and 80% of new FDA drug approvals being specialty medications, employers need to find ways to contain these costs.

• Niche: While there are a number of pharmacy solutions focused on the retail segment, there is only only one other company that we know of targeting home infusions as directly and comprehensively as Leap Health.

• Hard dollar savings: Embedded into the Leap Health business model is a highly transparent method of communicating the solution’s economic value, which will prove effective in discussions with employers, brokers, TPAs, and stop loss carriers.

POTENTIAL ISSUES

• Perception of provider quality: Potential customers may express concern around not receiving care in provider settings.

• Carrier and PBM resistance: The large, vertically integrated carriers and PBMs may resist embedding Leap Health into medical plans and formularies.

• Small patient population: The relative number of employees and dependents on specialty medications is <2%, so customers will need to be educated to focus on the cost problem to ensure prioritization and urgency.

Your thoughts

Here’s what you thought about last week’s startup, Hera Fertility: